Arbutus Biopharma (ABUS) Tops Q3 EPS by 20c

Arbutus Biopharma (NASDAQ: ABUS) reported Q3 EPS of ($0.17), $0.20 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target